Replies to post #811192 on NorthWest Biotherapeutics Inc (NWBO)

[seekinganswers]

LP and LL vibes here.

https://www.youtube.com/shorts/h1njoz5L5oI

[bas2020]

I wonder if any NWBO patents are being infringed upon with their vaccine process? How are they using/harvesting DCs?

A paradigm change would be to utilize the tumor itself in the body as an antigenic, vaccine source to generate long-term memory resulting in a durable response to the activated NK cell, T cell and memory T cell.

A paradigm change in cancer care is required in which a modernized treatment is based on the biology of the tumor independent of anatomy, utilizing molecular and immunological insights as to the dynamic state of the cancer in its evolution (elimination, equilibrium, and escape) and specifically tailored to the patient’s cancer altered genome, to reinstate the patient into equilibrium.
The notion that the tumor tissue itself could act as a source of both antigenicity and adjuvanticity is exploited by the NANT Cancer Vaccine – a universal therapeutic cancer vaccine that acts through the orchestration of the innate and adaptive immune system across all tumor types.